Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

C9orf72 Protein Plasmatic Concentrations Are Similar between C9ORF72 Expansion Carriers and Noncarriers in Frontotemporal Dementia.

Authors:
Anthony Fourier Maité Formaglio Mathilde Sauvée Armand Perret-Liaudet Philippe Latour Muriel Bost Isabelle Quadrio

Dement Geriatr Cogn Disord 2018 27;46(3-4):180-185. Epub 2018 Sep 27.

Neurochemistry and Neurogenetics Laboratory, Department of Biochemistry, Lyon University Hospital, Bron, France.

Background/aims: The aim of the study was to assess the theory of haploinsufficiency in C9ORF72 expansion carriers, the most frequent causative gene of frontotemporal dementia.

Methods: Plasmatic concentrations of C9orf72 protein were measured in 33 patients suspected of familial frontotemporal dementia using an enzyme-linked immunosorbent assay.

Results: No difference was observed between C9ORF72 expansion carriers (21.2% of patients) and noncarriers (78.8% of patients). C9orf72 protein determination is not a suitable biomarker for screening C9ORF72 expansion carriers.

Conclusion: Our results provide new evidence against the hypothesis of haploinsufficiency leading to frontotemporal dementia in C9ORF72 expansion carriers.

Download full-text PDF

Source
http://dx.doi.org/10.1159/000492963DOI Listing
January 2019

Publication Analysis

Top Keywords

c9orf72 expansion
20
expansion carriers
16
c9orf72 protein
12
frontotemporal dementia
12
concentrations c9orf72
8
plasmatic concentrations
8
c9orf72
8
expansion
5
screening c9orf72
4
familial frontotemporal
4
enzyme-linked immunosorbent
4
expansion carriersconclusion
4
dementia enzyme-linked
4
suspected familial
4
measured patients
4
carriersconclusion provide
4
dementiamethods plasmatic
4
protein measured
4
immunosorbent assayresults
4
frontotemporal dementiamethods
4

Altmetric Statistics


Show full details
2 Total Shares
1 News Outlets
1 Tweets
2 Citations

Similar Publications

Altered network properties in C9ORF72 repeat expansion cortical neurons are due to synaptic dysfunction.

Authors:
Emma M Perkins Karen Burr Poulomi Banerjee Arpan R Mehta Owen Dando Bhuvaneish T Selvaraj Daumante Suminaite Jyoti Nanda Christopher M Henstridge Thomas H Gillingwater Giles E Hardingham David J A Wyllie Siddharthan Chandran Matthew R Livesey

Mol Neurodegener 2021 Mar 4;16(1):13. Epub 2021 Mar 4.

Euan MacDonald Centre for MND Research, University of Edinburgh, Edinburgh, EH16 4SB, UK.

Background: Physiological disturbances in cortical network excitability and plasticity are established and widespread in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) patients, including those harbouring the C9ORF72 repeat expansion (C9ORF72) mutation - the most common genetic impairment causal to ALS and FTD. Noting that perturbations in cortical function are evidenced pre-symptomatically, and that the cortex is associated with widespread pathology, cortical dysfunction is thought to be an early driver of neurodegenerative disease progression. However, our understanding of how altered network function manifests at the cellular and molecular level is not clear. Read More

View Article and Full-Text PDF
March 2021
Similar Publications

The progress in research: ALS/FTD pathogenesis, functions and structure.

Authors:
Lan Jiang Tizhong Zhang Kefeng Lu Shiqian Qi

Small GTPases 2021 Mar 5:1-21. Epub 2021 Mar 5.

Department of Urology, State Key Laboratory of Biotherapy, West China Hospital, College of Life Sciences, Sichuan University, Chengdu, China.

The hexanucleotide repeat (GGGGCC) expansion in is accounted for a large proportion of the genetic amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). The hypotheses of how the massive G4C2 repeats in destroy the neurons and lead to ALS/FTD are raised and improving. As a multirole player, C9orf72 exerts critical roles in many cellular processes, including autophagy, membrane trafficking, immune response, and so on. Read More

View Article and Full-Text PDF
March 2021
Similar Publications

Chemical chaperones targeted to the endoplasmic reticulum (ER) and lysosome prevented neurodegeneration in a C9orf72 repeat expansion drosophila amyotrophic lateral sclerosis (ALS) model.

Authors:
Salome Azoulay-Ginsburg Michela Di Salvio Michal Weitman Michal Afri Sara Ribeiro Simon Ebbinghaus Gianluca Cestra Arie Gruzman

Pharmacol Rep 2021 Mar 4. Epub 2021 Mar 4.

Bar-Ilan University, 5290002, Ramat-Gan, Israel.

Background: ALS is an incurable neuromuscular degenerative disorder. A familiar form of the disease (fALS) is related to point mutations. The most common one is an expansion of a noncoding GGGGCC hexanucleotide repeat of the C9orf72 gene on chromosome 9p21. Read More

View Article and Full-Text PDF
March 2021
Similar Publications

C9orf72 ALS-FTD: recent evidence for dysregulation of the autophagy-lysosome pathway at multiple levels.

Authors:
Jimmy Beckers Arun Kumar Tharkeshwar Philip Van Damme

Autophagy 2021 Feb 26:1-17. Epub 2021 Feb 26.

Department of Neurosciences, Experimental Neurology, and Leuven Brain Institute (LBI), KU Leuven-University of Leuven, Leuven, Belgium.

Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are two clinically distinct classes of neurodegenerative disorders. Yet, they share a range of genetic, cellular, and molecular features. Hexanucleotide repeat expansions (HREs) in the gene and the accumulation of toxic protein aggregates in the nervous systems of the affected individuals are among such common features. Read More

View Article and Full-Text PDF
February 2021
Similar Publications

Genetic characterization of a cohort with familial parkinsonism and cognitive-behavioral syndrome: A Next Generation Sequencing study.

Authors:
Marina Picillo Monia Ginevrino Giovanna Dati Sara Scannapieco Annamaria Vallelunga Pietro Siano Giampiero Volpe Roberto Ceravolo Valentina Nicoletti Edoardo Cicero Alessandra Nicoletti Mario Zappia Silvia Peverelli Vincenzo Silani Maria Teresa Pellecchia Enza Maria Valente Paolo Barone

Parkinsonism Relat Disord 2021 Feb 2;84:82-90. Epub 2021 Feb 2.

Center for Neurodegenerative Diseases (CEMAND), Department of Medicine, Surgery and Dentistry, Neuroscience Section, University of Salerno, Italy. Electronic address:

Objective: To perform the genetic characterization of a cohort with familial parkinsonism and cognitive-behavioral syndrome.

Methods: A Next Generation Sequencing - based targeted sequencing of 32 genes associated to various neurodegenerative phenotypes, plus a screening for SNCA Copy Number Variations and C9orf72 repeat expansion, was applied in a cohort of 85 Italian patients presenting with parkinsonism and cognitive and/or behavioral syndrome and a positive familial history for any neurodegenerative disorder (i.e. Read More

View Article and Full-Text PDF
February 2021
Similar Publications
© 2021 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap